Evidence map›Paper›PMID 40430437›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Development and Characterization of an Injectable Alginate/Chitosan Composite Hydrogel Reinforced with Cyclic-RGD Functionalized Graphene Oxide for Potential Tissue Regeneration Applications.

Mildred A Sauce-Guevara, Sergio D García-Schejtman, Emilio I Alarcon, Sergio A Bernal-Chavez, Miguel A Mendez-Rojas

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mildred A Sauce-GuevaraDepartment of Chemical and Biological Sciences, Universidad de las Americas Puebla, Ex-Hacienda de Santa Catarina Martir s/n, San Andres Cholula, Puebla 72820, Mexico.ORCID 0000-0003-0902-8993
Sergio D García-SchejtmanBioengineering and Therapeutic Solutions (BEaTS) Program, University of Ottawa Heart Institute, Ottawa, ON K1Y 4W7, Canada.ORCID 0000-0003-1908-7348
Emilio I AlarconBioengineering and Therapeutic Solutions (BEaTS) Program, University of Ottawa Heart Institute, Ottawa, ON K1Y 4W7, Canada.
Sergio A Bernal-ChavezDepartment of Chemical and Biological Sciences, Universidad de las Americas Puebla, Ex-Hacienda de Santa Catarina Martir s/n, San Andres Cholula, Puebla 72820, Mexico.ORCID 0000-0001-9818-6517
Miguel A Mendez-RojasDepartment of Chemical and Biological Sciences, Universidad de las Americas Puebla, Ex-Hacienda de Santa Catarina Martir s/n, San Andres Cholula, Puebla 72820, Mexico.ORCID 0000-0002-4758-3763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alginatechitosangraphene oxidehydrogel compositeinjectabilitytissue regeneration

Identifiers

PMID40430437
PMCPMC12115116

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.